Ulcerative Colitis News and Research

Latest Ulcerative Colitis News and Research

Fecal transplant from certain donors better than others

Fecal microbiota transplantation or stool transplant from a donor is useful for patients infected with the deadly recurrent Clostridium difficile that leads to severe diarrhea, pain and often serious consequences.

22 Jan 2019

Researchers uncover specific microbial signatures of intestinal disease

Researchers from the Department of Biomedical Research of the University of Bern and the University Clinic of Visceral Surgery and Medicine of the Inselspital Bern, Switzerland, have discovered that changes in the composition of the intestinal bacteria in patients with chronic inflammatory bowel disease affect the severity of the disease and the success of therapy.

21 Jan 2019

Poo transplant can successfully treat patients with ulcerative colitis

Poo transplant or "Fecal microbiota transplantation" can successfully treat patients with ulcerative colitis, new research from the University of Adelaide shows.

16 Jan 2019

Scientists find link between colitis and colon cancer

Lingering inflammation in the colon is a known risk factor for colorectal cancer and now scientists report one way it resets the stage to enable this common and often deadly cancer.

14 Jan 2019

AGA's new clinical guideline to help manage patients with mild-to-moderate ulcerative colitis

Most patients with ulcerative colitis have mild-to-moderate disease characterized by periods of activity or remission, but practice variations exist in disease management.

10 Jan 2019

Women with IBD have increased risk of developing mental illness, finds study

A study published today in the journal Gut shows that women with inflammatory bowel disease are at greater risk of developing a mental illness after giving birth compared to the overall population.

10 Jan 2019

Microbial metabolite from pomegranates can reduce and protect against IBD

Scientists at the University of Louisville have shown that a microbial metabolite, Urolithin A, derived from a compound found in berries and pomegranates, can reduce and protect against inflammatory bowel disease.

10 Jan 2019

Metabolite from berries and pomegranates can mitigate inflammatory bowel disease

Millions of people suffer from inflammatory bowel disease worldwide, either in the form of ulcerative colitis or Crohn's disease, and few effective long-term treatments are available. Chronic intestinal inflammation is a hallmark of IBD.

9 Jan 2019

Allen Institute for Immunology: A new division focused on human immune system

The Allen Institute today announced the launch of the Allen Institute for Immunology, a new division of the Institute that is dedicated to studying the human immune system.

13 Dec 2018

Men with inflammatory bowel disease have higher prostate cancer risk

Men with inflammatory bowel disease have four to five times higher risk of being diagnosed with prostate cancer, reports a 20-year study from Northwestern Medicine.

7 Dec 2018

TARGET PharmaSolutions and Bristol Myers Squibb partner to advance IBD research

TARGET PharmaSolutions, Inc., a company focused on real-world evidence, is pleased to announce that Bristol Myers Squibb has entered into a strategic partnership for TARGET-IBD.

From Bristol-Myers Squibb 5 Dec 2018

Cellix Bio announces completion of Pre-IND meeting with FDA on novel prodrug of mesalamine for ulcerative colitis

Cellix Biosciences Inc., a development-stage pharmaceutical company, today announced successful completion of a Pre-Investigational New Drug meeting with the U.S. Food and Drug Administration for the development of CLX-103, a novel molecular conjugate of mesalamine for the treatment of mild to moderate ulcerative colitis.

30 Oct 2018

AbbVie’s U-ACHIEVE Phase 2b/3 dose-ranging study improves outcomes in patients with ulcerative colitis

AbbVie, a research-based global biopharmaceutical company, today announced positive results from U-ACHIEVE, an ongoing Phase 2b/3 dose-ranging study evaluating upadacitinib, an investigational JAK1-selective inhibitor, for induction and maintenance therapy in adult patients with moderately to severely active ulcerative colitis.

23 Oct 2018

Breathing through the nose improves memory consolidation

The way we breathe may affect how well our memories are consolidated (i.e. reinforced and stabilized). If we breathe through the nose rather than the mouth after trying to learn a set of smells, we remember them better, researchers at Karolinska Institutet in Sweden report in The Journal of Neuroscience.

22 Oct 2018

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Takeda Pharmaceutical Company Limited today announced results from the phase 3 VISIBLE 1 clinical trial evaluating the efficacy and safety of an investigational subcutaneous formulation of the gut-selective biologic vedolizumab for maintenance therapy in adult patients with moderately to severely active ulcerative colitis who achieved clinical response* at week 6 following two doses of open-label vedolizumab intravenous induction therapy.

22 Oct 2018

Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting

Gilead Sciences, Inc. and Galapagos NV today announced detailed results from the Phase 3 FINCH 2 clinical trial of filgotinib, an investigational, selective JAK1 inhibitor, in adults with moderately-to-severely active rheumatoid arthritis and prior inadequate response or intolerance to biologic agents.

22 Oct 2018

NSF awards $5 million grant to help scientists magnify societal impact of research

When Humira came on the market, many found relief from symptoms of arthritis, plaque psoriasis, Crohn’s disease and ulcerative colitis.

19 Oct 2018

Study reports increased risk of death in children with inflammatory bowel disease

Children who develop inflammatory bowel disease (ulcerative colitis or Crohn's disease) have an increased risk of death, both in childhood and later in life, a study from Karolinska Institutet in Sweden published in the journal Gastroenterology reports.

19 Oct 2018

International audit of colorectal surgeries provides highly realistic reflection of current practices

The European Society of Coloproctology has undertaken a major international audit of colorectal operations to understand which are most widely used techniques across the world, which appear to be associated with the best outcomes and where further research needs to be undertaken.

10 Oct 2018

Understanding immune system's balancing act could help in prevention, treatment of IBD

Australian researchers have uncovered clues in the immune system that reveal how the balance of 'good' gut bacteria is maintained. This information could help in the prevention and treatment of inflammatory bowel disease.

3 Oct 2018

Ulcerative Colitis News and Research

Latest Ulcerative Colitis News and Research

Fecal transplant from certain donors better than others

Researchers uncover specific microbial signatures of intestinal disease

Poo transplant can successfully treat patients with ulcerative colitis

Scientists find link between colitis and colon cancer

AGA's new clinical guideline to help manage patients with mild-to-moderate ulcerative colitis

Women with IBD have increased risk of developing mental illness, finds study

Microbial metabolite from pomegranates can reduce and protect against IBD

Metabolite from berries and pomegranates can mitigate inflammatory bowel disease

Allen Institute for Immunology: A new division focused on human immune system

Men with inflammatory bowel disease have higher prostate cancer risk

TARGET PharmaSolutions and Bristol Myers Squibb partner to advance IBD research

Cellix Bio announces completion of Pre-IND meeting with FDA on novel prodrug of mesalamine for ulcerative colitis

AbbVie’s U-ACHIEVE Phase 2b/3 dose-ranging study improves outcomes in patients with ulcerative colitis

Breathing through the nose improves memory consolidation

Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis

Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting

NSF awards $5 million grant to help scientists magnify societal impact of research

Study reports increased risk of death in children with inflammatory bowel disease

International audit of colorectal surgeries provides highly realistic reflection of current practices

Understanding immune system's balancing act could help in prevention, treatment of IBD

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Ulcerative Colitis News and Research

Latest Ulcerative Colitis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in